These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report. Taran A; Ignatov A; Smith B; Bischoff J; Costa SD Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073 [TBL] [Abstract][Full Text] [Related]
15. Development of single-agent chemotherapy regimens for gestational trophoblastic disease. Homesley HD J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517 [TBL] [Abstract][Full Text] [Related]
17. [Use of the laparoscope in the diagnosis and treatment of trophoblastic neoplasm]. Shi YF Zhonghua Yi Xue Za Zhi; 1984 Jul; 64(7):437-9. PubMed ID: 6097351 [No Abstract] [Full Text] [Related]
18. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia. Kohorn EI Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191 [TBL] [Abstract][Full Text] [Related]
19. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? Gillespie AM; Siddiqui N; Coleman RE; Hancock BW Br J Cancer; 1999 Mar; 79(7-8):1270-2. PubMed ID: 10098770 [TBL] [Abstract][Full Text] [Related]
20. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Dobson LS; Lorigan PC; Coleman RE; Hancock BW Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]